{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:39Z","timestamp":1791321999798,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.biologicals.2006.02.008","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T13:42:54Z","timestamp":1145454174000},"page":"87-90","source":"Crossref","is-referenced-by-count":19,"title":["Developments in the production and quality control of poliovirus vaccines \u2013 Historical perspectives"],"prefix":"10.1016","volume":"34","author":[{"given":"J.","family":"Furesz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2006.02.008_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.109.2822.85","article-title":"Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues","volume":"109","author":"Enders","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2006.02.008_bib2","unstructured":"Robbins FC. The history of polio vaccine development. In: Plotkin SA, Orenstein WA: Vaccines 4th ed. Saunders; 2004. p. 17\u201330."},{"key":"10.1016\/j.biologicals.2006.02.008_bib3","series-title":"Evaluation of the 1954 field trial of poliomyelitis vaccine","author":"Francis","year":"1957"},{"key":"10.1016\/j.biologicals.2006.02.008_bib4","first-page":"16","article-title":"The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. I. Background","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2006.02.008_bib5","first-page":"29","article-title":"The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2006.02.008_bib6","first-page":"61","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2006.02.008_bib7","series-title":"U.S. Public Health Service Technical Report on Salk poliomyelitis vaccine","year":"1955"},{"key":"10.1016\/j.biologicals.2006.02.008_bib8","first-page":"29","article-title":"Virus inactivation: lessons from the past","volume":"75","author":"Melnick","year":"1990","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2006.02.008_bib9","unstructured":"Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine \u2013 live, in: Plotkin SA, Orenstein WA: Vaccines 4th ed. Saunders; 2004. p. 651\u2013705."},{"key":"10.1016\/j.biologicals.2006.02.008_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3181\/00379727-107-26576","article-title":"Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts","volume":"107","author":"Eddy","year":"1961","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.biologicals.2006.02.008_bib11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198112173052507","article-title":"Long-term follow-up of persons inadvertently inoculated with SV40 as neonates","volume":"305","author":"Mortimer","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2006.02.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a112197","article-title":"Human exposure to SV40: review and comment","volume":"103","author":"Shah","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biologicals.2006.02.008_bib13","unstructured":"Requirements for poliomyelitis vaccine, oral. WHO Technical Report Series No. 273;1962; No. 687;1983; No. 800;1990; No. 897;2000 ; No. 904;2002."},{"key":"10.1016\/j.biologicals.2006.02.008_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/216064a0","article-title":"Growth of cell-strains and primary cells on micro-carriers in homogenous culture","volume":"216","author":"van Wezel","year":"1967","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.biologicals.2006.02.008_bib15","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1093\/clinids\/6.Supplement_2.S345","article-title":"Inactivated poliovirus vaccine and test development at Connaught Laboratories Ltd","volume":"6","author":"von Siefried","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.biologicals.2006.02.008_bib16","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/clinids\/6.Supplement_2.S335","article-title":"Inactivated poliovirus vaccine: current production and new developments","volume":"6","author":"van Wezel","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.biologicals.2006.02.008_bib17","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1093\/clinids\/6.Supplement_2.S341","article-title":"Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier","volume":"6","author":"Montagnon","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.biologicals.2006.02.008_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/vim.1990.3.243","article-title":"Production of poliomyelitis vaccines: past, present and future","volume":"3","author":"Duchene","year":"1990","journal-title":"Viral Immunol"},{"key":"10.1016\/j.biologicals.2006.02.008_bib19","first-page":"108","article-title":"Immune response in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus","volume":"55","author":"Koprowski","year":"1952","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2006.02.008_bib20","series-title":"Poliomyelitis: papers and discussions. Presented at the 5th international poliomyelitis conference","article-title":"Field safety and efficacy of live attenuated poliovirus vaccines","author":"Payne","year":"1961"},{"key":"10.1016\/j.biologicals.2006.02.008_bib21","unstructured":"WHO Expert Committee on Poliomyelitis. WHO Technical Report Series No. 203;1960."},{"key":"10.1016\/j.biologicals.2006.02.008_bib22","first-page":"143","article-title":"The work of the WHO Consultative Group on poliomyelitis vaccines","volume":"66","author":"Cockburn","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2006.02.008_bib23","first-page":"61","article-title":"Some aspects of the monkey neurovirulence test used for the assessment of oral poliomyelitis vaccines","volume":"78","author":"Furesz","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2006.02.008_bib24","first-page":"925","article-title":"Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus","volume":"40","author":"WHO Consultative Group","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2006.02.008_bib25","first-page":"739","article-title":"Safety of oral poliomyelitis vaccine: results of a WHO enquiry","volume":"66","author":"Esteves","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2006.02.008_bib26","first-page":"251","article-title":"Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study","volume":"81","author":"Dragunski","year":"2003","journal-title":"Bull World Health Organ"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105606000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105606000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T21:57:45Z","timestamp":1547675865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105606000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1045105606000340"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2006.02.008","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}